Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal SDF

被引：0
|
作者：
Mota, T. M. [1 ]
Khoury, G. [1 ]
Jacobson, J. C. [1 ]
Lu, H. K. [1 ]
Wightman, F. [1 ]
Van der Sluis, R. M. [1 ]
Anderson, J. L. [1 ]
Cameron, P. U. [1 ,2 ]
Lewin, S. R. [1 ,2 ]
Purcell, D. F. J. [1 ]
机构：
[1] Univ Melbourne, Doherty Inst Infect & Immun, Melbourne, Australia
[2] Alfred Hlth & Monash Univ, Dept Infect Dis, Melbourne, Australia
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
THPDA0104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
    Taylor, Jared P.
    Armitage, Lucas H.
    Aldridge, Daniel L.
    Cash, Melanie N.
    Wallet, Mark A.
    BIOLOGY OPEN, 2020, 9 (12):
  • [32] New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
    Lewis, Catherine A.
    Margolis, David M.
    Browne, Edward P.
    VIRUSES-BASEL, 2023, 15 (08):
  • [33] Impact of latency-reversing agents on human macrophage physiology
    Hany, Laurent
    Turmel, Marc-Olivier
    Barat, Corinne
    Ouellet, Michel
    Tremblay, Michel J.
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (01)
  • [34] Latency Reversing Agents: Kick and Kill of HTLV-1?
    Schnell, Annika P.
    Kohrt, Stephan
    Thoma-Kress, Andrea K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [35] Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
    Relano-Rodriguez, Ignacio
    Juarez-Sanchez, Raquel
    Pavicic, Carolina
    Munoz, Eduardo
    Angeles Munoz-Fernandez, Maria
    JOURNAL OF NANOBIOTECHNOLOGY, 2019, 17
  • [36] Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
    Ignacio Relaño-Rodríguez
    Raquel Juárez-Sánchez
    Carolina Pavicic
    Eduardo Muñoz
    Maria Ángeles Muñoz-Fernández
    Journal of Nanobiotechnology, 17
  • [37] HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal
    Moso, Michael A.
    Anderson, Jenny L.
    Adikari, Samantha
    Gray, Lachlan R.
    Khoury, Georges
    Chang, Judy J.
    Jacobson, Jonathan C.
    Ellet, Anne M.
    Chen, Wan-Jung
    Saleh, Suha
    Zaunders, John J.
    Purcell, Damian F. J.
    Camerona, Paul U.
    Churchill, Melissa J.
    Lewin, Sharon R.
    Lu, Hao K.
    AIDS, 2019, 33 (02) : 199 - 209
  • [38] HIV CURE: VALIDATING X AS A NOVEL THERAPEUTIC TARGET IN HIV LATENCY REVERSAL USING RNA INTERFERENCE
    O'Reilly, S.
    Crowley, N.
    Le Douce, V
    Gautier, V. W.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S462 - S462
  • [39] Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control
    Heinson, Ashley I.
    Woo, Jeongmin
    Mukim, Amey
    White, Cory H.
    Moesker, Bastiaan
    Bosque, Alberto
    Spina, Celsa A.
    Woelk, Christopher H.
    Macarthur, Ben D.
    Beliakova-Bethell, Nadejda
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (02) : 109 - 121
  • [40] Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells
    Lachlan R. Gray
    Hung On
    Emma Roberts
    Hao K. Lu
    Michael A. Moso
    Jacqueline A. Raison
    Catherine Papaioannou
    Wan-Jung Cheng
    Anne M. Ellett
    Jonathan C. Jacobson
    Damian F. J. Purcell
    Steve L. Wesselingh
    Paul R. Gorry
    Sharon R. Lewin
    Melissa J. Churchill
    Journal of NeuroVirology, 2016, 22 : 455 - 463
12345